Immune Status of Elderly Population Admitted in an Acute Geriatric Unit

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

78 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2012-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ageing is associated with vulnerability against infections leading to increased morbidity with risk of death. Innate and adaptive immunities are altered with ageing responsible of deficits in immune response against pathogens and after vaccination, and favouring the elderly vulnerability against a new pathogen with increased bacterial, viral, and fungal infections.

If immunity has been widely studied in immunosenescence, there are few prospective, comparative studies with elderly ill patients. Moreover among these studies, pathologies are not well defined.

The main objective of our project is to compare the immune state of elderly hospitalised subjects in an acute geriatric unit to the immune state of elderly healthy subjects selected with strict criteria, in order to precise the impact of polypathology and of various pathologies on immunity state.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Age and Geriatric Co-morbidities on Lymphocyte Phenotype in Patients 70 Years of Age and Older

NCT04772092

Geriatrics Immunosenescence

WITHDRAWN

COVID-19 Serology and Immunosenescence

NCT04563650

Covid19 Geriatric Medicine Seroconversion +1 more

ACTIVE_NOT_RECRUITING NA

Bedside Assessment of Immune Function in Patients With Covid-19

NCT06879548

Covid19

WITHDRAWN

Immune Changes in Severe COVID-19 Pulmonary Infections

NCT04386395

SARS-CoV-2 Immune System Disorder

COMPLETED

Link Between Eosinopenia and Bacterial Infections in the Elderly Subject Hospitalized in Geriatrics

NCT04363138

Fever Leukocytes C Reactive Protein (CRP) is Less Than 20 mg/ l

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

pathological group

Group Type EXPERIMENTAL

Blood test and clinical test

Intervention Type OTHER

Blood test and clinical test

healthy aged

Group Type EXPERIMENTAL

Blood test and clinical test

Intervention Type OTHER

Blood test and clinical test

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood test and clinical test

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject of 75 or more years old, female or male
* Subject admitted in the service of short stay gériatrique of the hospital Holy Marguerite, whatever is the motive for admittance
* Subject not being under supervision(guardianship), nor guardianship
* Subject benefiting from a benefit system
* Subject having given its assent of participation or for which the reliable person gave her assent in the case of vulnerable person

Exclusion Criteria

* Subject of less than 75 years old
* Subject refusing to participate in the study or for whom(which) the reliable person refuses the participation of the subject

Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes